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Edited by Laszlo Nagy and Peter TontonozAbstract Neuronal control of body energy homeostasis is the
key mechanism by which animals and humans regulate their
long-term energy balance. Various hypothalamic neuronal cir-
cuits (which include the hypothalamic melanocortin, midbrain
dopamine reward and caudal brainstem autonomic feeding sys-
tems) control energy intake and expenditure to maintain body
weight within a narrow range for long periods of a life span.
Numerous peripheral metabolic hormones and nutrients target
these structures providing feedback signals that modify the de-
fault ‘‘settings’’ of neuronal activity to accomplish this balance.
A number of molecular genetic tools for manipulating individual
components of brain energy homeostatic machineries, in combi-
nation with anatomical, electrophysiological, pharmacological
and behavioral techniques, have been developed, which provide
a means for elucidating the complex molecular and cellular
mechanisms of feeding behavior and metabolism. This review will
highlight some of these advancements and focus on the neuronal
circuitries of energy homeostasis.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Feeding and energy metabolism is a basic and vital life pro-
cess essential for individual and, consequently, species sur-
vival. It could be argued that the emergence and evolution
of the central nervous system is to promote the most eﬀective
means of dealing with feeding and metabolism in support of
survival. Accumulating experimental evidence is in agreement
with this basic assertion. Thus, it is not unreasonable to claim
that even higher brain regions, such as the archio- and neocor-
tex, emerged under environmental pressures to support behav-
iors that more eﬀectively deal with available energy resources.
The pursuit to understand the role that the brain plays in the
control of body energy balance has continued for more than a
century, when patients with pituitary adenomas were initially
observed to rapidly gain body weight [1,2]. Increasingly*Corresponding author. Address: Section of Comparative Medicine,
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doi:10.1016/j.febslet.2007.11.063sophisticated technologies and methods have since been
brought to bear on the topic and a vast number of observa-
tions have been made, particularly within the last decade
due to the cloning of the product of the obesity (ob) gene, lep-
tin, the mutation of this gene causes obesity in rodents [3],
which brought about a wave of discovery of other metabolic
hormones, neuropeptides and signaling pathways, and estab-
lished their relationship to key neuronal structures in the
hypothalamus [4–7]. Based upon these fundamental ﬁndings,
the studies of more complex signal intergrations and neuronal
adaptations that actually initiate changes in ingestive behavior
and metabolism have become possible. This review will follow
this line of research history and highlight some important new
advances.2. Discovery of the brain regions that control energy balance
The initial observations ofMohr and Frohlich [1,2] regarding
pituitary adenomas led to the hypothesis that adenoma-related
obesity is caused by damage to the hypothalamus [8]. This
important idea was supported by the observation that obesity
developed in an experimental dog given that underwent a hypo-
thalamic lesion [9]. The actual identiﬁcation of speciﬁc hypo-
thalamic structures that are directly involved in energy
homeostasis, however, was accomplished about three decades
later, when a set of systematic lesion experiments was per-
formed in rats, in which various hypothalamic nuclei that in-
clude the hypothalamic ventromedial (VMH), paraventricular
(PVH) and dorsomedial (DMH) nuclei were destroyed. The
lesions of these nuclei induced hyperphagia and obesity [10–12];
whereas, lesions in the lateral hypothalamus (LH) led to hypo-
phagia [13]. This study, which stands as a milestone in linking
brain function to body energy balance, led to the proposal of
a ‘‘dual center model’’ that identiﬁed the hypothalamic VMN
as the ‘‘satiety centre’’, and the LH as the ‘‘hunger centre’’
[14]. More studies, including chemical lesions as well as phar-
macological applications of various hormones and drugs,
which either stimulate or inhibit the neuron populations
locally, have since been done and all supported the initial
observations that lead to the proposed ‘‘dual center model’’.
In retrospect to our current knowledge of speciﬁc hypothalamic
neuronal populations, these lesion studies are strikingly precise
in distinguishing between subregions that contain circuits that
either promote or suppress feeding. These ﬁndings have since
been used as a road map for studies concerning the neurobiol-
ogy of feeding and metabolism.blished by Elsevier B.V. All rights reserved.
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The brain regions that control energy homeostasis, by deﬁni-
tion, need to ‘‘know’’ the amount of pre-existing body energy
stores in order to ‘‘wisely’’ determine the levels of energy in-
take and expenditure. The nature of the signal(s) that conveys
such information to the brain was the subject of a couple of
hypotheses. The ‘‘glucostatic hypothesis’’, [15] suggested that
small changes in plasma glucose levels trigger meal initiation
or termination. This ‘‘depletion–repletion’’ model of energy in-
take correlated well with the initiation or termination of feed-
ing per se, however, it did not provide information about or a
mechanism by which to ensure that food consumption with re-
spect to existing energy stores would be appropriate and it cor-
related poorly with energy expenditure [16]. The ‘‘lipostatic
model’’, on the other hand, hypothesized that signal(s) propor-
tional to the amount of fat in the body modulates the amount
of food eaten at each meal to maintain overall energy balance
[17]. Later discoveries have supported this hypothesis that
food intake is controlled within a lipostatic system to maintain
energy homeostasis.
The ﬁndings from the initial parabiosis studies on hypotha-
lamic lesioned rats appear to be essential to the conclusion of
the existence of humoral signal(s) in relation to an animals
lipostatics [18]. In these studies, two live animals, one with a
lesion in the VMH, were joined by suturing, which allowed
humoral factors to pass from one animal to the other. As obesity
developed in the lesioned rat, its partner became hypohagic
and lost weight, suggesting that a signal, in proportion to the
amount of fat mass, is highly potent in inhibiting food intake.
Additional parabiosis studies on genetically obese mutant
mice, ob/ob and db/db [19,20], concluded that ob/ob mice lack
this lipostatic signal, whereas db/db mice are insensitive to it.
These hypotheses were later conﬁrmed by the discoveries of
the ob gene that encodes leptin [3] and the db gene that encodes
leptin receptor.
The detection of leptin and its receptor soon led to the
recognition that all of the hypothalamic nuclei associated with
energy regulation, i.e., the VMH, DMH, PVN and LH, are
regions where leptin receptors are highly expressed. This
promoted a new ﬂourish of gene discoveries, which identiﬁed
novel neuropeptides, their receptors and transcription factors
that mediate leptin function in the hypothalamus and subse-
quently, led to the discovery of the hypothalamic melanocortin
system, the key neuronal system in the control of energy bal-
ance by leptin signaling. Other metabolic signals, such as insu-
lin, ghrelin, estrogen, prolactin, glucocorticoids, resistin and
interleukins, etc., as well as nutrients such as glucose and free
fatty acids [21–23], which, to a certain extent, modify energy
balance and body weight, also target the hypothalamic mela-
nocortin system [16,5,24–26], presumably in coordination with
leptin function.4. The importance of the melanocortin system in energy
homeostasis
The melanocortin model has held the most signiﬁcance in
explaining the neuronal control of energy balance. In this
model, the hypothalamic arcuate nucleus (ARC) is considered
a critical region for various reasons. First, the neurons within
the ARC are anatomically placed in close proximity to fenes-trated capillaries at the base of the hypothalamus, giving them
access to humoral signals that are restricted from other regions
of the brain [27,28]. Indeed, they respond rapidly to ﬂuctua-
tions in nutrients [7,29] and metabolic hormones. These neu-
rons are also innervated by axons containing all major
neurotransmitters and express receptors for most metabolic
hormones [5,27,30,31], implying that an extensive neuronal
control exists. Finally, they project broadly to the brain and
periphery both directly as well as indirectly.
Two sets of neurons, with opposite eﬀects on feeding, have
been identiﬁed in the ARC. The neurons that express proopi-
omelanocortin (POMC) and cocaine-amphetamine regulated
transcript (CART) are anorexigenic [32–34], due to the release
of the cleavage products of POMC precursor, a-, and b-mela-
nocyte stimulating hormones (a- and b-MSH) [34]. These, in
turn, reduce food intake and body weight as well as increase
energy expenditure in animals and humans [35–37] by acting
on melanocortin receptor subtypes 3 and 4 (MC3 and 4R)
[38], found to be abundant in the ARC, PVN, LH and
DMH [39]. In contrast, cells containing neuropeptide Y
(NPY) and the agouti gene related transcript (AgRP) are orex-
igenic [40]. NPY potently stimulates food intake and reduces
energy expenditure [41]. In genetically obese animals, i.e., ob/
ob and db/db mice, as well as those in a negative energy state,
i.e., fasted or lactating animals, the ARC NPY mRNA and
protein content are elevated [42–45]. AgRP acts as a natural
antagonist of MC3R and MC4R, thereby, reducing the ano-
rectic eﬀect of a-MSH [40,46–48]. An ectopic expression of
Agouti, an AgRP like peptide, results in an obese phenotype
of the yA agouti mouse [40].
The selective expression of ﬂuorescent reporter genes in spe-
ciﬁc neurons allows for the visualization of hypothalamic neu-
ronal subpopulations so that they can be studied in the context
of feeding circuits while the cells are still alive. Through the use
of this method, substantial neuroanatomical and electrophysi-
ological data have been generated, which demonstrate that
NPY neurons contact nearby POMC cells and inhibit them
through the release of GABA [49]. This unidirectional NPY
to POMC interaction [50] may represent a wiring blueprint
that favors the tonic inhibition of satiety signals to not only
promote feeding, but also overfeeding when food is available
in excess [51].
The ARC POMC and NPY neurons project to various parts
of the brain, e.g., the PVN, LH and perifornical hypothalamic
region, all of which contain substantial numbers of MC3 and 4
receptors [39,52]. The projection from the ARC to the PVN is
important for the regulation of neurons that produce cortico-
tropic and thyrotropin releasing hormones (CRH and TRH,
respectively) and for the modulation of sympathetic activity,
both of which are signiﬁcant mechanisms in energy metabo-
lism ([53], Fig. 2). A recent study using a cre/loxP genetic ap-
proach showed that mice with mutations to the MC4R gene
(loxTB mc4) ate and weighed less if the MC4R gene was re-
stored selectively in the PVN [54]. However, it was not suﬃ-
cient to bring energy expenditure levels to those of controls,
suggesting that energy expenditure is regulated by melanocor-
tins elsewhere in the hypothalamus and/or through receptors
other than MC4R [54].
Recent studies showed that intact melanocortin neuronal
circuitry is important for acute regulation of feeding [55,56].
These studies stemmed from the considerable frustration
encountered due to the fact that neither NPY nor AgRP single
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mice [58] exhibited the expected hypophagia. To examine
whether the NPY and POMC neurons themselves are crucial
in adult energy regulation, whereas the loss of NPY/AgRP
or POMC genes may be compensated for during development,
both groups had used the cell-targeted expression of diphteria
toxin receptors that do not exist in mice, making these animals
‘‘immune’’ to diphtheria toxin-induced necrosis. When the
otherwise normally developing diphtheria toxin receptor
expressing mice were injected with two subsequent doses of
diphtheria toxin, the targeted hypothalamic neurons rapidly
died resulting in hypophagia in NPY neuron-ablated mice
[55] and hyperphagia in POMC neuron-ablated animals [55].
Interestingly, the ablation of NPY neurons during the early
postnatal period did not result in an overt metabolic pheno-
type, indicating that functional eﬀects of degenerated neurons
in critical developmental periods may be overcome by re-orga-
nization of the circuits.5. The function of satiety center, VMH: does it modulate the
melanocortin circuits?
The VMH was directly implicated in feeding when Hethe-
rington and Ranson showed that electrolytic lesions to this
region in rats resulted in rapid development of obesity
[10,59,11,12]. Chemical lesions as well as pharmacological
studies have since supported the notion that the VMH inhibits
feeding and increases metabolism and by doing so, restricts the
amount of body fat [60,61]. The VMH was found to highly
express the long form leptin receptor, LRb, and, therefore, is
the region that mediates leptins eﬀect on homeostasis
[62,63]. Despite the early discovery of the anorexic eﬀect of
the VMH, little is known regarding the cellular mechanisms
by which VMH neurons contribute to homeostasis under the
control of leptin signals.
Recent studies, however, show that the VMH is equally
important and functions alongside the ARC in energy regula-
tion in response to leptin [64]. These studies examined the
behavioral and metabolic phenotype of animals with the leptin
receptor selectively deleted in POMC neurons [65]. Surpris-
ingly, these animals were at best only mildly obese and ate sim-
ilar amounts of food as controls. In contrast, a selective
deletion of the leptin receptor gene in the neurons that express
steroid factor-1 (SF-1) in the VMH results in mice that are not
only obese but also hyperphagic [66,67]. SF-1 is a transcription
factor necessary for the development of the VMH [68–70].
Mice with mutations to leptin receptors in both the ARC
POMC and the VMH SF1 neurons are more obese than those
with mutations of leptin receptors in either set of neurons
alone [67].
How do VMH neurons act to deliver the anorectic eﬀect in
the context of hypothalamic feeding circuits? A recent study
showed that the VMH may directly increase the activity of
POMC neurons via microcircuits [71] that were previously dif-
ﬁcult to detect by conventional tracing techniques [72–74].
Using laser scanning photo-stimulation (LSPS) in combination
with slice electrophysiology, these authors showed that the
inputs from the VMH neurons are mostly excitatory, thus
increasing the activity of POMC cells; during a fast, these
inputs decrease [71]. Whether or not these VMH neurons
receive leptin signaling requires further investigation.Conversely, the ARC may also modulate the activity of the
VMH. Although aﬀerent projections from the ARC to the
VMH are sparser than those to other nuclei [73], the VMH
contains MC4R as well as NPY Y1, Y2 and Y5 receptors
[75–80], suggesting that both POMC and NPY neurons project
to the VMH. Infusions of NPY into the VMH increase feed-
ing; fasting is associated with elevated levels of NPY in this re-
gion [75,5], whereas electrophysiological responses of neurons
in the VMH to a-MSH are decreased in animals that are fasted
and/or treated with AgRP prior to sacriﬁce than in animals
that have free access to food [80].
A notable characteristic of the VMH is that it highly and spe-
ciﬁcally expresses the brain-derived neurotrophic factor
(BDNF) that has been shown to aﬀect the metabolic functions
regulated by the VMH. Genetic deﬁciencies of BDNF or its
TrkB receptor resulted in obesity in both humans and mice
[81,82]. Interestingly, leptin increases BDNF transcripts [83–
86], whereas fasting decreases them selectively in the VMH, sug-
gesting that the BDNF is a regulatory component of leptin sig-
naling. Since BDNF in the brain is known to promote synaptic
morphology and function [81], this raises the possibility that
synaptic plasticity in the hypothalamusmay be a part of the reg-
ulatory mechanism of energy regulation. Notably, the anorectic
eﬀects of BDNF are not directly mediated by the melanocortin
system since BDNF reduces the body weight and food intake of
mice that lack the MC4R [82], yet neurons in the VMH form
excitatory microcircuits with POMC neurons in the ARC [71],
suggesting that the VMH may inﬂuence POMC neuroactivity
by othermeans, such as classic neurotransmitters and/or plastic-
ity. Indeed, leptin and other hormones increase the number of
excitatory synapses on POMC cells [87,88].6. The lateral hypothalamic arousal-feeding system
In the lateral hypothalamus (LH), two sets of neurons that
contain either hypocretin (orexin), a peptide implicated in arou-
sal and feeding, or melanin-concentrating hormone (MCH),
another potent stimulator of food intake, have been identiﬁed.
These neurons are innervated by both POMC and NPY termi-
nals, suggesting that their function in motivating food intake is
also within the conﬁnes of the ARC melanocortin system [89–
93,48,94–99]. Both MCH and hypocretin neurons have a wide
projection ﬁeld and modulate a variety of behavioral responses
related to learning, memory, emotion, motivation and motor
responses in association with changes in the energy state
[100,92,101,102,97]. Although the projections of MCH and
hypocretin neurons exhibit signiﬁcant overlap, their overall ef-
fects and actual targets are quite diﬀerent [100,96]. Like that of
the NPY and POMC neurons, the activity of MCH and hypo-
cretin neurons is regulated by numerous hormones that include
leptin and ghrelin, as well as by practically every neurotrans-
mitter system [91,103–106]. Within the LH,MCH and hypocre-
tin neurons have reciprocal connections with each other, and
with nearby neurons [99]. Electrophysiological studies in brain
slices or isolated neurons indicated that hypocretin, in general,
has a stimulative eﬀect on LH neurons includingMCH neurons
[107,108], whereas MCH depresses the synaptic activity of glu-
tamate and GABA neurons from the rat LH [109]. It is not clear
whether such electrical interactions between hypocretin and
MCH neurons, at the intensities and dynamics observed, are
more relevant to feeding or arousal behavior.
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bolic signals to modulate energy balance, more or less, inde-
pendent of each other, despite their proximate location and
physiological interaction in the LH. The mRNA levels of hyp-
ocretin in the LH are up-regulated upon fasting [93]. Hypocre-
tin neurons are rapidly activated by fasting in rodents and non-
human primates [110] and exhibit leptin-dependent synaptic
plasticity during fasting [111]. Moreover, all of the hypotha-
lamic neurons that are activated by fasting receive strong hyp-
ocretin input. These observations, together with the earlier
demonstration of a massive hypocretin input to the ARC, par-
ticularly to the NPY neurons [112], as well as the dependence
of hypocretin function on NPY signaling (in particular on the
Y1 and Y5 receptors) [113,114], and a synergistic action be-
tween NPY and hypocretin (at low concentrations) to induce
feeding [115] argue that hypocretin neurons may be upstream
to the NPY system with regard to feeding and metabolism.
Mice with deletions of the hypocretin gene are hypophagic,
but maintain normal growth curves, suggesting that their met-
abolic rates are reduced [116]. This, in association with the crit-
ical role of hypocretin neurons to promote arousal [117]
through direct projections to the brain stem, including the
locus coeruleus [112] make the hypocretin neurons a likely
candidate to provide the link between obesity and insomnia.
The orexigenic peptide MCH, on the other hand, shows little
or no interaction with NPY or hypocretin in inducing food in-
take when injected together into the third ventricle of the rat
[115]. This observation provides a physiological component
concomitant to the pre-existing morphological data that shows
that the strength of MCH projections to the ARC is limited
compared to that of the hypocretin neurons. Thus, the action
of MCH on feeding is likely independent of NPY and hypocre-
tin. However, like NPY, MCH does exhibit characteristics of
orexigenic genes: its mRNA levels are increased in obese mu-
tant animals and fasting further increases its expression in
both normal and obese animals [89]; and it has a potent orex-
igenic eﬀect. Targeted deletion of the MCH gene resulted in a
phenotype of hypophagia and leanness with an inappropri-
ately high metabolic rate [118], suggesting that MCH is a typ-
ical ‘‘thrift gene’’ that increases energy intake and reduces
energy expenditure simultaneously. Consistent with this idea,
MCH suppresses thyroid stimulating hormone (TSH) release
[119].
The orexigenic eﬀect of MCH appears to compete with the
action of a-MSH (a mechanism conserved from skin color reg-
ulation in ﬁsh to hypothalamic control of energy balance in
mammals), such that MCH administration increases feeding,
while a-MSH acts to decrease it. When the peptides are admin-
istered together, depending on the relative ratios, one antago-
nizes the action of the other [92]. Recently, a mouse model of
MCH neuron ablation was generated by expressing a toxin
gene, ataxin-3, targeted at MCH neurons [120]. Mice that ex-
press this gene have a chronic loss of MCH neurons. Interest-
ingly, the phenotype of these mice highly resembles that of
mice lacking only the MCH gene, exhibiting reduced food in-
take and increased energy expenditure. Moreover, the ablation
of MCH neurons in mice with an ob/ob mutant background
improved obesity and glucose tolerance. These results suggest
that the function of MCH cells in energy regulation is limited
to the MCH system itself, but not to other aspects of the cells
such as their classic neurotransmitter function and/or synaptic
plasticity, which are distinct from NPY cells.7. Other hypothalamic regions that regulate food intake and
body weight
Receptors for leptin and ghrelin are also found in other
hypothalamic nuclei including the DMH and the suprachias-
matic nucleus (SCN) [103,121]. The DMH has been implicated
in the regulation of energy balance, however, its actual role re-
mained obscure until recently [122–124]. The DMH is involved
in a variety of regulatory mechanisms that include the modu-
lation of glucocorticoid secretion, body temperature, arousal,
and circadian rhythms of locomotor activity [123]. The
DMH receives inputs from cells in the ARC and from brain
stem centers that are also implicated in feeding [122]. Lesions
restricted to the DMH typically result in hypophagia, although
animals can still maintain their body composition [122].
Recently, the DMHwas shown to be critical for the entrainment
of circadian rhythms to feeding schedules [124]. The DMH of
animals with restricted access to food (4 h/day) had increased
expression of c-Fos, indicating an increased cellular activation
at a time when the food was regularly presented compared to
animals that had free access to food throughout the day. Ibote-
nic lesions of the DMH resulted in reduced levels of locomotor
activity and decreased food intake. Furthermore, when
lesioned rats were placed in the restricted feeding schedule,
they showed less preprandial increases in food anticipatory
locomotor activity than those of sham operated animals.
DMH lesions also blocked the rise in body temperature that
is entrained to the timing of food presentation [124]. The pheno-
type of cells within this region remains obscure. A number of
these cells produce glutamate as a neurotransmitter and pro-
ject to the PVN as well as to the preoptic area, both thought
to be involved in the circadian regulation of corticosteroid
secretion and body temperature [125,122]. Projections from
the DMH to the LH and to the ventrolateral preoptic area
have been implicated in sleep and arousal and could presum-
ably relate to the enhanced activity of animals in restricted
feeding schedules [126].
The role of the SCN in energy balance has been overshad-
owed by the critical role of this region as a master clock that
mediates circadian patterns of biological function [127].
Among these, the SCN controls the circadian secretion of met-
abolic hormones and is thought to regulate seasonal adipose
tissue content and maintain patterns of glucose levels
[128,129]. The SCN projects to most hypothalamic nuclei, with
a strong projection that terminates in the PVN and DMH
[127]. Recent evidence suggests that the ARC projects to the
SCN as well, indicating that the melanocortin system can inﬂu-
ence its activity [130]. Importantly, mice with mutations of the
clock gene, a transcript expressed in the SCN and critical for
the generation of circadian rhythms, exhibit an obese pheno-
type [131]. Hypothalamic clock gene expression is highest in
the SCN, thus directly implicating this region in obesity caused
by this mutation [132,133].8. Midbrain dopamine system – the motivation or reward to eat
The midbrain dopamine system is known to be involved in
the regulation of arousal, locomotor activity, mood and reward
[134]. Dopamine deﬁciency in mice, generated by selective inac-
tivation of tyrosine hydroxylase, markedly suppresses food in-
take in a manner similar to that of lesions of the LH [135,136].
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[137], as well as to PYY administration or leptin deﬁciency
[138], suggesting that dopamine signaling is absolutely required
for promoting feeding and acts downstream of the melanocor-
tin system. Among the various functions of the dopamine sys-
tem, the reward pathways have received particular attention in
explaining feeding behavior given the universality of food as a
natural reinforcer. Dopaminergic neurons within the midbrain
ventral tegmental area (VTA) that innervate the nucleus
accumbens (the ventral striatum) have been implicated in the
rewarding aspects of food, sex, and drugs of abuse [139]. In sup-
port of a role for the mesolimbic reward circuitry in feeding reg-
ulation, it was recently found that interfering with ghrelin
signaling speciﬁcally in the VTA diminished ghrelin-induced
feeding [140]. Surprisingly, however, the restoration of dopa-
mine production within the dorsal striatum restores feeding
on normal chow, whereas restoration of dopamine in the nu-
cleus accumbens does not. While these ﬁndings may suggest a
fundamental diﬀerence between feeding for nourishment and
food as a rewarding substance [141], a similar study in human
subjects argues in the same vein: by using [(11)C]raclopride pos-
itron emission tomography (PET) scanning, feeding was found
to be associated with dopamine release in the dorsal, but not the
ventral striatum, and yet the amount of dopamine released cor-
related with the degree of pleasure experienced [142]. Thus, fur-
ther investigations are needed to discern the role of VTA versus
nigral dopamine neurons in the regulation of feeding and en-
ergy homeostasis in general [143,144].
Nevertheless, feeding is associated with motivational mecha-
nisms important for the behavioral responses necessary for
seeking food [145]. Hypothalamic peptides like NPY, a-
MSH, AgRP, hypocretin and MCH, on the other hand, modu-
late the activity of dopaminergic neurons that target the nucleus
accumbens [146]. The ARC funnels metabolic information
from signals like leptin to modulate the activity of the mesolim-
bic dopaminergic system via direct projections to the nucleus
accumbens, or indirectly through the activation of hypocretin
orMCH neurons that also project to both the VTA and nucleus
accumbens [146]. Emerging evidence, however, supports the
idea that at least the VTA is sensitive to leptin, insulin and ghre-
lin, and that the activity of dopaminergic neurons within the
VTA can be modulated by these signals [147,148,121]. The
implications of these observations remain controversial. Fur-
ther research may reveal that, in contrast to the funnel hypoth-
esis, metabolic signals could act directly on reward systems,
including the dorsal striatum, to modulate motivational aspects
of feeding in tandem with homeostatic systems [149,148].9. The caudal brainstem: autonomic control of eating
The caudal brainstem contains neurons and circuits that in-
volve autonomic control of ingestion, digestion, and absorp-
tion of food [150], and do so without forebrain inﬂuence
[151], just as for respiration and circulation, the functions
essential for survival. Thus, the regulation of nutrient supply
is to a large extent autonomically organized within the brain-
stem that generates most of the parasympathetic support dur-
ing ingestive and digestive processes through the vagus nerve,
as well as sympathetic responses related to severe energy deple-
tion and energy expenditure. It has immediate access to thelocomotor and oromotor apparatuses that enable approach
of food and orchestrate ingestion of food and ﬂuid placed into
the oral cavity. Furthermore, the brainstem can terminate
ingestion when the taste is aversive or when visceral sensors
detect noxious stimuli. Thus, complete ingestive behavior
and energy balance cannot occur without the circuits of the
brainstem [152].
Interestingly, the caudal brainstem is involved in the control
of meal size by signals arising from the mouth and gastrointes-
tinal tract based upon the chemical or mechanical properties
of food, which are relayed to the nucleus of the solitary tract
(NST) via the vagus and other cranial nerves [153]. In a
chronic decerebrate rat preparation, the taste concentrations,
gastric preloads and cholecystokinin (CCK; a peptide released
from intestinal endocrine cells during feeding) all aﬀected the
meal size in a manner similar to that of intact rats. Thus,
the brainstem isolated from its forebrain connection exhibits
the basic behavior of satiety [154]. This challenges the classic
view that hypothalamic integration of visceral signals is neces-
sary for the behavioral output that determines meal size. The
speciﬁc neural pathways necessary for the ‘‘satiety’’ response
have not yet been identiﬁed. CCK appears required for the
‘‘satiety’’ response [155], which also involves neurons in the
NTS as well as the dorsomotor nucleus of the vagus
(DMV), and is blocked by vagal deaﬀerentiation [156]. In
addition to meal size control, decerebrate rats also show a
fully formed sympathoadrenal response to systemic 2DG
administration [157], indicating that the brainstem houses a
complete system responsive to glucoprivation. However,
decerebrate rats are not able to increase meal size appropri-
ately in response to food deprivation [158], and, therefore,
have an inadequate response to a long-term homeostatic chal-
lenge, which requires interactions between hypothalamic and
caudal brainstem nuclei [152].
Consistent with these ﬁndings, the peripheral hormones lep-
tin, ghrelin and insulin, neuropeptides a-MSH and CRH as
well as nutrients such as glucose all yield potent eﬀects on
food intake and body weight similar to their eﬀects in the
hypothalamus [152,151]. LRbs are found throughout the dor-
sal vagal complex (DVC, area postrema, nucleus of the soli-
tary tract, dorsal motor nucleus of the vagus nerve) and in
various other structures in the caudual brainstem [159]. Local-
ized stimulation of these receptors reduces food intake and
body weight [160]; Ghrelin receptors, GHS-R are expressed
in the area postrema and nucleus tractus solitarius of the
brainstem. Stimulation of GHS-R in the caudal brainstem
led to a hyperphagic response [161,162]. Ghrelin delivered to
the fourth ventricles signiﬁcantly increased cumulative food
intake, with maximal response approximately 3 h after injec-
tion. In a separate experiment, ghrelin microinjected unilater-
ally into the dorsal vagal complex (DVC) signiﬁcantly
increased food intake measured 1.5 and 3 h after treatment
[163]. Insulin receptors are also found in the NST [164]. Fur-
thermore, unilateral DVC injection of both MC3/4 R and
CRH1/2R agonists resulted in suppression of food intake,
while a MC3/4R antagonist induced hyperphagia [165–167].
The innervation of the brainstem by the perifornical and
far-lateral hypothalamic MCH neurons has recently been
identiﬁed [168]. Lastly, it is noteworthy that the brainstem
also houses glucose-sensitive neurons that are involved in
the sympathoadrenal and ingestive responses to glucopenia
in rodents [169].
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Despite the complex and extensive involvement of the brain
in energy homeostasis, a basic picture of the neuronal control
behind this process is emerging. In this representation, the mel-
anocortin system, broadly deﬁned to include the hypothalamic
ARC, VMH, DMH, PVN and LH, is positioned at the center,
with the other brain regions, such as the midbrain dopamine
system (controlling the motivation to eat or reward of eating)
and the caudal brainstem (autonomic control of eating) posi-
tioned downstream. The key molecule that connects the entire
network is the adipokine leptin, which conveys information
from the periphery regarding pre-existing energy stores to
the brain. These neuronal structures are all targeted, diﬀeren-
tially, by leptin to modify their default settings, which other-
wise tend to increase energy intake and reduce energy
expenditure. Although close interactions between individual
nuclei have been found, these nuclei and neuronal subpopula-
tions act more or less in parallel but are not hierarchical.
This relatively simpliﬁed representation of the neuronal con-
trol of energy regulation highlights several issues that still need
to be addressed. These include: (1) an intricate and detailed
labeling of all of the LRb expressing neurons in the brain, with
particular attention given to the hypothalamus, midbrain and
brainstem, in order to identify novel neuronal subpopulations,
speciﬁcally in the VMH, DMH and LH. In fact, this work is
already quickly progressing (personal communication, Myers);
(2) focusing on neuronal adaptations, e.g., electrophysiological
and plastic, directly induced by the metabolic hormones, leptin
and ghrelin, that actually alter feeding behavior and/or metab-
olism; (3) discerning the particular eﬀect of each nucleus and/
or neuronal subpopulation in relation to homeostasis; identify-
ing the niche, through which diﬀerent neuronal circuits inter-
act, and, more importantly, addressing the logic behind the
parallel arrangement of brain structures/systems that control
long-term energy balance.
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